Social media

From prescriptions to patient demographics, Metys®, from Symphony Health, an ICON plc company, sees it all. With over 150+ metrics – from diagnosis subgroups to payer mis – you get the full picture, not just a snapshot....

Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...

Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, suc...

2025 has seen both the EMA and the FDA publish new position papers and opinions on streamlining the trial process for biosimilars. On the surface, reducing reliance on comparative efficacy trials has the potential to sav...

There is great excitement following the announcements by the FDA and EMA around streamlining the biosimilar trial process. They promise to reduce the burden on developers and therefore increase the number of more afford...

USP compounding may be fast — but is it costing you quality, compliance, and insight? In this insightful session, our experts discussed: - Why GMP manufacturing offers a strategic edge in early phase trials - Real-worl...

USP compounding may be fast — but is it costing you quality, compliance, and insight? In this insightful session, our experts discussed: - Why GMP manufacturing offers a strategic edge in early phase trials - Real-worl...

Bringing together safety and efficacy data from multiple studies can be complex. This blog outlines practical approaches to preparing an Integrated Summary of Safety and Efficacy (ISS/ISE) that supports clear, consiste...

Bringing together safety and efficacy data from multiple studies can be complex. This blog outlines practical approaches to preparing an Integrated Summary of Safety and Efficacy (ISS/ISE) that supports clear, consiste...

ICON is proud to be part of #SCDMIndia, happening 4–6 December in Hyderabad. Meet us at booth \#22 and discover how our team is shaping the future of clinical data management through innovation and expertise. Don’t miss ...

ICON is proud to be part of #SCDMIndia, happening 4–6 December in Hyderabad. Meet us at booth #22 and discover how our team is shaping the future of clinical data management through innovation and expertise. Don’t miss t...

To increase engagement and retention in clinical trials, reduce burden on participants. By enabling participation from the comfort of home, digital health technologies help: - Improve retention - Increase diversity - ...